Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCCR in Prader-Willi Syndrome
NCT03440814Phase 3Completed
- Sponsor
- Soleno Therapeutics
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of diazoxide in Prader-Willi syndrome (PWS), sponsored by Soleno Therapeutics. Started May 2018; status: completed.
02
Drugs
diazoxide
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT03440814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03440814.